We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 9138W
GlaxoSmithKline PLC
29 April 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) I give details of changes in the notional interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR'), who acquired Ordinary Shares and American Depositary Shares ('ADSs'), at a price of 1502.00 pence per Ordinary Share and $42.64 per ADS, following the re-investment of dividends paid to Shareholders on 14 April 2016, on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.
Director/PDMR Number of Ordinary Number of Ordinary Shares acquired Shares acquired under the personal under the matching contribution element of the element of the plan (GSK contribution) plan --------------------- --------------------- -------------------------- Sir Andrew Witty 3,883.790 3,883.790 --------------------- --------------------- -------------------------- Mr S Dingemans 2,089.773 2,089.773 --------------------- --------------------- -------------------------- Mr R G Connor 858.228 858.228 --------------------- --------------------- -------------------------- Mr N Hirons 548.422 548.422 --------------------- --------------------- -------------------------- Mr S A Hussain 1,556.838 1,556.838 --------------------- --------------------- -------------------------- Mr D S Redfern 1,077.470 1,077.470 --------------------- --------------------- -------------------------- Ms C Thomas 1,271.298 1,271.298 --------------------- --------------------- -------------------------- Mr P C Thomson 460.665 460.665 --------------------- --------------------- -------------------------- Dr P J T Vallance 2,084.049 2,084.049 --------------------- --------------------- -------------------------- Ms E Walmsley 1,506.621 1,506.621 --------------------- --------------------- -------------------------- Director/PDMR Number of ADSs Number of ADSs acquired under acquired under the personal the matching contribution element of the element of the plan plan (GSK contribution) ----------------- ----------------- --------------------- Dr M M Slaoui 1,543.193 1,543.193 ----------------- ----------------- --------------------- Mr D E Troy 846.539 846.539 ----------------- ----------------- ---------------------
GlaxoSmithKline plc ('GSK') was advised of these allocations on 28 April 2016.
V A Whyte
Company Secretary
29 April 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQKLFLQZFLBBL
(END) Dow Jones Newswires
April 29, 2016 12:23 ET (16:23 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions